Mice lacking Sirt2 spontaneously develop tumors in multiple organs, as well as when expressed in combination with oncogenic Kras G12D , leading to pancreatic tumors. Here, we report that after caerulein-induced pancreatitis, Sirt2-deficient mice exhibited an increased inflammatory phenotype and delayed pancreatic tissue recovery. Seven days post injury, the pancreas of Sirt2 −/− mice display active inflammation, whereas wild-type mice had mostly recovered. In addition, the pancreas from the Sirt2 −/− mice exhibited extensive tissue fibrosis, which was still present at six weeks after exposure. The mice lacking Sirt2 also demonstrated an enhanced whole body pro-inflammatory phenotype that was most obvious with increasing age. Importantly, an accumulation of a cell population with spontaneous cancerous Kras G12D mutations was observed in the Sirt2 −/− mice that is enhanced in the recovering pancreas after exposure to caerulein. Finally, transcriptome analysis of the pancreas of the Sirt2 −/− mice exhibited a pro-inflammatory genomic signature. These results suggest that loss of Sirt2, as well as increased age, enhanced the immune response to pancreatic injury and induced an inflammatory phenotype permissive for the accumulation of cells carrying oncogenic Kras mutations.
Sirtuin genes are the human and murine homologs of the S. cerevisiae Sir2 gene that have been shown to direct both metabolism and lifespan 1 . In addition, sirtuins play a role in longevity by directing critical acetylome signaling networks in response to caloric restriction 2 . Sirtuin 2 (SIRT2) is a member of sirtuin family of NAD + -dependent deacetylases that are linked to multiple biological and pathological processes, such as the cell cycle, DNA repair, metabolic homeostasis, genomic integrity, and tumorigenesis. Originally, SIRT2 was observed to regulate the cell cycle 3 through the deacetylation of H4K16ac 4 but later was shown also to function in metabolic processes by inhibiting adipogenesis by deacetylating FOXO1 and facilitating lipolysis by repressing PPARγ activity 5 . SIRT2 also directs other physiological processes, including gluconeogenesis, insulin sensitivity, and fatty acid oxidation [6] [7] [8] , and is critical for insulin-dependent AKT activation, suggesting that the inhibition of SIRT2 may have an impact on cancer growth 9 .
We have shown that mice lacking Sirt2 develop tumors in multiple organs, including pancreatic ductal adenocarcinomas (PDAC) 10 , and interestingly, the combination of Sirt2 deletion with an oncogenic Kras G12D mutation induces PDAC at three months 11 . In this regard, it has also been shown that KRAS is a SIRT2 downstream deacetylation target that directs enzyme activity 12 . Ninety-five percent of patients diagnosed with PDAC have tumors with a KRAS mutation. However, the percentage of oncogenic mutant KRAS in healthy organs, including the pancreas, are at rates far exceeding the incidence of cancer development. Furthermore, KRAS GTPase
Results
Sirt2 deficiency impairs pancreatic regeneration. It has been previously shown that loss of Sirt2 accelerates the oncogenic properties of oncogenic Kras G12D , and these tumors exhibited an increase in trichrome staining suggesting a potential pro-inflammatory environment in pancreatic cells lacking Sirt2 11 . To address this question, we used a well-established model to induce pancreatitis by 8 hourly intraperitoneal (i.p.) injections of 100 μg/kg caerulein. After two days post injection, wild-type and Sirt2 −/− mice exposed to caerulein were sacrificed and both showed similar patterns of moderately severe histological damage (Fig. 1a ), and scores of tissue integrity, acinar cell necrosis, as well as inflammatory cell infiltration (Fig. 1b ,c) (Supplemental Section, Table S1 , for histological scoring criteria). In contrast, wild-type mice pancreas appear to mostly recover at day 7 post injection; however, pancreatic regeneration was severely impaired in Sirt2 −/− mice, and the inflammation score remained ~70% of day 2 (Fig. 1a-c) . Taken together, these results suggest that loss of Sirt2 led to delayed pancreas tissue recovery after caerulein-induced acute pancreatitis, suggesting SIRT2 may play role in pancreatic tissue regeneration.
Loss of Sirt2 deficiency leads to inflammatory cell infiltration following caerulein exposure.
To determine whether loss of Sirt2 affects the inflammatory cell infiltration in pancreatic tissue during a course of acute caerulein exposure, we assessed the IHC staining of a macrophage maker F4/80. Wild-type and Sirt2 −/− mice displayed a similar F4/80 + IHC staining in macrophages infiltrating into the pancreatic tissue at day 2 ( Fig. 2a , left and middle panels), as compared to PBS-injected controls. In contrast, F4/80 + staining macrophage infiltration was still observed in Sirt2 −/− mice at day 7 ( Fig. 2a , right panels).
The local pancreatic inflammatory response was assessed in isolated pancreas in Sirt2 −/− mice and wild-type mice at day 7 post injection ( Fig. 2b,c ). CD45 + macrophages were increased by caerulein-induced acute pancreatitis in the pancreas from both wild type and Sirt2 −/− mice, and the induced levels for both were maintained at day 7 to a similar extent. However, the myeloid-derived suppressor cell (MDSC) population (CD45 + CD11b + Gr-1 + ) was significantly higher in pancreas from Sirt2 −/− mice as observed in spleen confirming sustained pancreatitis at day 7. Next, we examined whether the whole body CD45 + CD11b + Gr-1 + have been changed in the spleen following caerulein injection. The increase of the CD45 + CD11b + Gr-1 + population positively correlates with inflammation and being cancer bearing. A high proportion of CD45 + CD11b + Gr-1 + cells were observed in the spleen of Sirt2 −/− mice compared to wild-type mice at D7 after the last injection ( Fig. 2d,e ). IFN-γ producing CD4 + T cells and serum level of IFN-γ also remained high in Sirt2 −/− mice at day 7 (Supplemental Section, Fig. S1 ). Pancreatic tissue damage, as well as macrophage infiltration, was also abnormal, as compared to control mice, up to at least 21 days after the induction of pancreatitis (Supplemental Section, Figs S2 and S3). Since SIRT2 regulates NF-κB activities 29 , we assessed the NF-κB activity in pancreas from wild-type and Sirt2 −/− mice at day 7. The expression levels of NF-κB target genes, Pdgfra (Platelet Derived Growth Factor Receptor Alpha), Fcer1g (Fc Fragment Of IgE Receptor Ig), and Ccl2 (C-C Motif Chemokine Ligand 2) were determined by RT-qPCR and showed sustained NF-κB activity at day 7 in Sirt2 −/− mice (Supplemental Section, Fig. S4 immunological response in pancreas from Sirt2 −/− mice at day 7. Finally, when a chronic pancreatitis model was used, via injection of a lower concentration of caerulein into mice (50 μg/kg, 6 hourly injections once a week for 6 weeks), the pancreas from the Sirt2 −/− mice also exhibited more intense tissue damage ( Fig. 3a,b ) and macrophage infiltration ( Fig. 3c,d ) although there is no difference in body weight (Fig. 3e ). The results of these in vivo experiments suggest that loss of Sirt2 prolonged the whole body inflammatory response by caerulein-induced acute and chronic pancreatitis.
Effect of Sirt2 deficiency on immune response by age. Sirt2-deficient mice showed prolonged inflammation in caerulein-induced acute pancreatitis, suggesting that these mice may have intrinsic problems with their immune response. Our previous finding that Sirt2-deficient mice developed pancreatic cancer with an oncogenic mutant Kras background 11 also supports our notion since tumor development is closely linked with the increasing age partly due to the impaired immune system integrity 33 .
To study the effects of Sirt2 deficiency on the systemic immune response, age-matched mice were analyzed by flow cytometry to determine the age-related changes in immune cell proportions, such as CD4 + T cells, CD8 + T cells, active T cells (CD4 + CD69 + ), Tregs (CD4 + CD25 + Foxp3 + ), and MDSCs (CD45 + CD11b + Gr-1 + ) in the spleen. Compared to the wild-type mice, the Sirt2 −/− mice exhibited an increase in the percentage of the total CD4 + T cells and a decrease in the percentage of total CD8 + T cells in the spleen of 12-month old mice ( Fig. 4a,b ). In addition, the Sirt2 −/− mice also exhibited an increased proportion of activated T cells (CD4 + CD69 + , Fig. 4c ) and Tregs (CD4 + CD25 + Foxp3 + , Fig. 4d ) in the spleen of 12-month old mice, but not in 4-month old mice. Notably, Sirt2 deletion leads to a higher proportion of inflammatory CD45 + CD11b + Gr-1 + cells and CD45 + CD11b + Gr-1 − cells, such as red pulp macrophages in the spleen of 12-month old, but not 4-month old mice ( Fig. 4e,f) . These results suggest that loss of Sirt2 shows enhanced inflammatory responses during aging, even without exposing an agent that induces an inflammation response.
Loss of Sirt2 leads to elevated serum amylase and prolonged fibrosis. To monitor tissue damage
and regeneration of the pancreas in a caerulein-induced model for acute pancreatitis, the wild-type and Sirt2 −/− mice pancreas were stained for CK19, amylase, and DAPI. Wild-type mice, 7 days after exposure, showed a predominate amylase staining pattern, an acinar marker consistent with tissue recovery (Fig. 5a ) while in contrast, the Sirt2 −/− mice exhibited significant CK19 staining, a ductal marker indicating the presence of tissue damage Fig. 5a ). In addition, the levels of serum amylase in the Sirt2 −/− mice were also significantly higher, as compared to wild-type mice, at day 2 and 7 post caerulein injection, indicating sustained tissue and prolonged damage has occurred in mice lacking Sirt2 (Fig. 5b) . Pancreatic fibrosis is a characteristic histopathological feature of chronic pancreatitis due to tissue injury. Pancreatic fibrosis, as measured by Masson's Trichrome staining, was similar in both the wild-type and Sirt2 −/− mice on day 2 post injection, as seen by the blue stained areas ( Fig. 5c , middle panel). The expression level for α-smooth muscle actin (α-SMA) as a fibrosis marker was also similar between wild-type and Sirt2 −/− mice (Supplemental Section, Fig. S5 ). At day 7 post injection, the pancreas from wild-type mice were mostly recovered, and only sporadic blue sections were found ( Fig. 5c , right-upper panel, Fig. 5d ). In contrast, pancreas from Pancreas from wild-type and Sirt2 −/− mice treated with PBS or caerulein at D7 were harvested, digested, and single cells were isolated and stained with anti-CD45, anti-CD11b, and anti-Gr-1 antibodies. (d) FACS plots characterized the expression of CD45 + cells in wild-type, and Sirt2 −/− mice at D7. Wild-type and Sirt2 −/− mice were i.p. injected with PBS or caerulein, and the spleen was removed at D7. Splenic cells were isolated and stained with anti-CD45, anti-CD11b, and anti-Gr-1 antibodies. Scatterplots showed the population of CD45 + CD11b + Gr1 + myeloid cells in wild-type and Sirt2 −/− mice at D7 (circled). Enhanced accumulation of spontaneous Kras mutations in Sirt2 knockout mice at 7 days after caerulein-induced pancreatitis. Pancreatic cell KRAS mutations, which commonly occur at amino acid position 12, glycine (G), to valine (V) or aspartic acid (D), are a very early precancerous event [34] [35] [36] and are also found in normal cell populations 15, 37 . In addition, pancreatic fibrosis is also a high-risk factor for PDAC 38 . Taken together, we hypothesized that the pro-inflammatory/pro-fibrotic permissive phenotype observed in mice lacking Sirt2 may select for cell populations that exhibit growth advantages, such as carrying an oncogenic Kras mutation. Indeed, a cross relationship between inflammation and KRAS mutations has been suggested previously 2,39-42 .
To address this question, we have analyzed pancreatic genomic DNA obtained from wild-type and Sirt2 −/− mice 7 days after caerulein-induced pancreatitis by competitive allele-specific TaqMan Mutation Detection Assays (using castPCR technology) for KRAS amino acid codon mutations at position 12 for glycine to valine (Kras G12V ) or aspartic acid (Kras G12D ) (Fig. 6 ). The detection cut-off value was set to 0.1%, as recommended by the manufacturer's protocol, and pancreas from 46 wild-type (28 treated with caerulein and 18 non-treated) and 56 Sirt2 −/− (28 treated with caerulein and 28 non-treated) mice were subjected to analysis. A Kras G12D mutation was detected in 3.5% of the wild-type mouse pancreas at day 7 after caerulein injection, with no Kras G12V mutations (Fig. 6a, upper column) . In contrast, 17.8% of the mice lacking Sirt2 exhibited a Kras mutation (Kras G12D = 7.1%, Kras G12V = 10.7%) at day 7 after caerulein exposure (lower column). Kras mutations were also observed in untreated Sirt2 −/− mice (12 to 25-month-old) with 14.3% of Kras G12D mutation in Sirt2 −/− mice versus none observed in wild-type mice (Fig. 6a-c) . We confirmed Kras mutation detection results by TaqMan PCR detection with a completely different design of primer set from Integrated DNA Technologies (IDT) (data not shown). These results indicate that Sirt2 −/− mice accumulated Kras mutations in the pancreas at a frequency of more than 5 times higher than that of wild-type mice through a caerulein-induced pancreatitis.
To confirm the presence of KRAS-G12D mutant protein, we performed immunohistochemistry with an antibody specific for G12D mutation in mouse KRAS (Fig. 6d ). We detected multiple KRAS-G12D mutant protein islands in Sirt2 −/− but not in wild-type pancreas 7 days after caerulein-induced pancreatitis. These results strongly support our hypothesis that the absence of Sirt2 provides a growth advantage for cells originally carrying oncogenic Kras mutations.
Identification of differentially expressed genes in Sirt2 −/− mice pancreas on day 2 post caerulein. Histopathological analyses show that pancreas from mice lacking Sirt2 exhibited delayed tissue recovery following caerulein exposure. To extend these results at the molecular level and gain insight of a potential mechanism of delayed pancreatic recovery, RNA-seq gene expression profiling was performed. A heat map, from pancreatic RNA in wild-type and Sirt2 −/− mice, with and without caerulein exposure, on day 2 showed clear differences in expressed genes (Fig. 7a) . Overall, we have identified 529 differentially expressed genes (322 up-regulated genes and 207 down-regulated genes, fold-change >1.5, p < 0.05) as part of the top up-and down-regulated genes (Fig. 7b, Supplemental Section, Fig. S9 ).
The KEGG pathway analysis revealed 17 up-regulated and 9 down-regulated enriched pathways in Sirt2 −/− mice on day 2 post caerulein-induced pancreatitis (Fig. 7c) . Notably, up-regulated pathways included those related to extracellular matrix (ECM) reorganization, cell growth and death, and nutrition regulation, suggesting an active reorganization of ECM due to the continuous cell death and cell growth requiring high nutrition in the Sirt2 −/− pancreas.
Glycosaminoglycan, including heparin sulfate proteoglycans (HSPGs), biosynthesis is also an enriched pathway in the pancreas of Sirt2 −/− mice exposed to caerulein. HSPGs are expressed in most cell surfaces and essential for embryogenesis. HSPGs also play important roles in modulating secreted signaling molecules, including growth factors and cytokines 43 .
Aggressive "scrap and build" processes are enriched in "pathways in cancer". Within this category, there are multiple changes in growth factor receptors' expression including insulin-like growth factor 1 receptor (Igf1r), fibroblast growth factor receptor 3 (Fgfr3), and positive regulators of the Ras pathway, such as nuclear receptor coactivator 4 (Ncoa4), and segment polarity Wnt pathway proteins dishevelled homolog Dvl2 and Dvl3. Other positive and/or negative cell growth regulatory genes identified include the glucose metabolism regulatory gene Ncoa4, peroxisome proliferator-activated receptor gamma (PPARγ), zinc finger, BTB domain-containing protein 16 (Zbtb16), and laminin subunit alpha-2 (Lama2), an extracellular matrix (EMC) reorganization gene actively involved in cancer development.
The "Lysine degradation" pathway is also enriched in the Sirt2 −/− mouse, and these genes are involved in pathways that convert lysine to acetyl-coenzyme A (CoA), which is a critical intermediate molecule for lipid metabolism and ATP synthesis, all of which are essential to cell growth and survival. The Ingenuity Pathway Analysis (IPA) also revealed that ECM regeneration was one of the major pathways significantly upregulated in the pancreas from Sirt2 −/− mice (Supplemental Section, Fig. 9 ). Importantly, the IPA independently showed that the pancreas from Sirt2 −/− mice 2 days after exposure exhibit tumorigenic "cell death and survival" genomic profile. Finally, the characterization of these differentially expressed genes is shown. Overall, the transcriptome pathway enrichment analysis supports the notion, at the molecular level, that the regeneration of pancreatic tissue appears to still be occurring at 2 days post pancreatitis induction in Sirt2 −/− mice.
Validation of differentially expressed genes at day 2 post pancreatitis induction. To confirm
the RNA-seq results, the mRNA levels of Ncoa4, Igf1r, Fgfr3, and Zbtb16, which belong to the "Pathways in cancer", were validated by RT-qPCR, and collectively, the expression of these genes is increased in the Sirt2 −/− mice (Fig. 8a ). In addition, the expression of (Glycosaminoglycan biosynthesis -heparin sulfate) ( Fig. 8b) , as well as Ncor2 in "Notch signaling pathway" (Fig. 8c ), were also higher in Sirt2 −/− mice exposed to caerulein, as compared to control mice. In contrast, the expression of Cldn18 (Cell adhesion molecules, CAMs), is decreased in Sirt2 −/− mice exposed to caerulein. These results confirm the RNA-seq data, and thus, support the results from the pathway enrichment analysis. We further confirmed differential expression in protein level by immunohistochemical stain for IGF1R and CLDN18 (Supplemental Section, Fig. S8a ) and by western blotting for FGFR3 (Supplemental Section, Fig. S8b ).
Discussion
We have reported previously that mice lacking Sirt2, which also express a Kras G12D mutation, develop pancreatic cancer 11 . Acute or chronic inflammation in the pancreas has been demonstrated to be susceptible to oncogenic Kras-mediated transformation 38 , and loss of Sirt2 leads to a pro-inflammatory phenotype, at least in some part, due to the dysregulation of the acetylation status of the NF-κB subunit 29 . Thus, we proposed that mice lacking Sirt2 might exhibit a pancreatitis permissive phenotype, as well as Kras mutations. In this regard, we have shown that pathologically obvious pancreatic tissue damage was observed at 7 days after the last injection of caerulein, which continued up to at least 6 weeks, suggesting that mice lacking Sirt2 exhibit a pancreatitis permissive phenotype. In addition, transcriptome analysis revealed differential gene expression patterns, at early time points, indicating that pancreatitis in Sirt2 −/− mice display enrichment of pathways related to tissue injury and inflammation.
Kras mutations are present in the pancreas of healthy individuals 37 , and it seems reasonable to assume that an enhanced inflammatory response or increasing age may play a role, at least in some part, in this process. Caerulein is considered an analogue to cholecystokinin (CCK), a natural hormone synthesized and secreted by enteroendocrine cells in the duodenum, which induces pancreatic enzyme secretion and an inflammatory response 44, 45 . Since sirtuins, including SIRT2, play a role both in aging and the immune response, we hypothesized that caerulein exposure might create a mutagenic environment. Our results clearly show that oncogenic Kras Gly12 mutations accumulate after caerulein-induced pancreatitis especially in Sirt2 −/− mice possibly due to a growth advantage of oncogenic Kras mutation. This result is an important evidence to postulate a mechanism of how inflammation contributes to the oncogenic Kras mutation initiated pancreatic cancer and show another scientific murine model example of multidimensional interactions between the inflammatory microenvironment and oncogenic Kras mutations [40] [41] [42] . Recently, it has been reported that inflammation induced Kras-independent pancreatic cancers in p53 −/− mice 46 . Their results imply that Kras mutation is not preferred during tumorigenesis when DNA repair checkpoint is disrupted (p53-null). This could mean that Kras mutations have a potential to escape from p53-dependent genomic integrity severance mechanism or to overcome the elimination pressure by the tumor suppressor function of p53.
Recently, Boggs et al. reported transcriptome profiling results by RNA-seq in the recovering pancreas from caerulein-induced pancreatitis 47 . They have acquired transcriptome data at 7 days and 14 days post caerulein-induced pancreatitis, and since the experimental system they used was similar to our study, we have compared their 7 days post pancreatitis expression profiling data with our 2 days post pancreatitis expression profiling data (Supplemental Section, Figs S10 and 11 ). The heat map depicts a total of 4,102 statistically significant (fold-change >1.5, p-value < 0.05) differentially expressed genes (up-regulated 2066 genes, down-regulated 2036 genes) from our data, which is larger than that of Boggs et al. (total 319 genes), possibly due to the date of the analysis. We have focused on the initial stage of pancreatic tissue regeneration to observe the initial difference in recovery pathway between Sirt2 −/− mice and wild type mice, and Boggs et al. analyzed 7 days after pancreatitis in wild type mice when most of the inflammatory response is gone. Indeed, Venn diagrams (Supplemental Section, Fig. S11 ) revealed that nearly half of the differentially expressed genes identified by Boggs et al. overlapped with our data, and a large number of genes are unique for our analysis. Pathway analysis in each category in the Venn diagram (Supplemental Section, Figs S11-13) indicated that the common enriched pathways for both groups related to EMC regeneration, whereas the pathways specifically enriched in ours (Quan et al.) are related to cell growth, cell death, and inflammation, supporting the pathological differences in 2 days and 7 days post caerulein-induced pancreatitis that we observed. These results confirmed at the molecular level that 2 days post caerulein-induced pancreatitis is an early time point of pancreatic tissue regeneration. In closing, our results demonstrate that mice lacking Sirt2 exhibit a pancreatic inflammation permissive phenotype, as well as accumulate oncogenic Kras mutations that is accelerated during recovery from caerulein-induced pancreatitis. Since our previous results have shown that Sirt2 −/− mice carrying the Kras G12D mutant progress to pancreatic cancer 11 , there is a reasonable possibility to assume that spontaneous Kras Gly12 mutations accumulated during pancreatitis that could increase the risk of PDAC later in life. Indeed, it has been shown that the level of NAD + , an essential substrate for sirtuin activity, declines in the pancreas with age in mice 48 . If the decrease in SIRT2 activity in the pancreas accelerates the accumulation of oncogenic Kras mutations, it seems reasonable to propose that caerulein-induced pancreatitis in Sirt2 −/− mice would be a useful model system for spontaneous Kras mutation-initiated pancreatic cancer in humans.
Methods
Animals. Acute pancreatitis (AP) was induced into 4-5-month-old female and male Sirt2 wild-type and knockout mice by 8 hourly intraperitoneal injection of caerulein (100 μg/kg) (Sigma, St. Louis, MO) for one day. Chronic pancreatitis was induced in mice by 6 hourly intraperitoneal injection of caerulein (50 μg/kg) (Sigma, St. Louis, MO) once a week for 6 weeks. Age-matched control mice were administered comparable injections of PBS. For all experiments, age-and sex-matched mice were used, and the same background wild type mice served as controls. Injection procedures were performed as outlined in our murine protocols that have been approved by Northwestern University's Institutional Animal Care and Use Committee (IACUC, institutional protocol number: 2012-2989). For all experiments, age-and sex-matched mice were used, and the same background wild type mice served as controls. The mice were sacrificed at various time points (day 1, day 2, and day 7) after the last injection, and the tissues were taken for subsequent analyses. Mice were housed and bred in pathogen-free conditions at Northwestern University's barrier facility with a 12-hour light-dark cycle and could obtain food and water ad libitum. All animal housing, handling, and experimental procedures were conducted in strict accordance to the National Institutes of Health and IACUC guidelines. The Northwestern animal resources program is under the direction of full-time veterinarians and is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. Northwestern complies with the NIH policy on animal welfare, the Animal Welfare Act, and all other applicable federal, state and local laws.
Histological scoring. Pancreatic tissues were fixed in 10% formalin for 24 hrs at room temperature with slow shaking and embedded in paraffin blocks. Paraffin-embedded tissue samples were cut into 4-μm-thick sections, deparaffinized in xylene, and rehydrated through a graded series of ethanol solutions. To evaluate the pancreatic tissue damage, Hematoxylin-eosin staining was performed. The severity of acute pancreatitis was quantified by assessment of tissue integrity, acinar cell necrosis, and inflammatory cell infiltration. The individual scores and combined scores for these three categories were performed by 3 random images from 5 slides and shown in Supplemental Table 1 . To detect tissue fibrosis, the sections were also subjected to Masson's Trichrome staining. The intensity of stromal fibrosis was scored as: 0: Absent; 1: <5%; 2: 5-10%; 3: 10-20%; 4: >20% fibrosis.
Immunohistochemistry and immunofluorescence. Pancreatic tissues were fixed in 10% formalin, embedded in paraffin, cut into 4-μm-thick sections. Paraffin sections were deparaffinized in xylene, rehydrated by ethanol gradient, and then heated in a pressure cooker in a citrate-based antigen retrieval buffer. The sections were blocked and incubated with primary antibody α-F4/80 (1:200; Cat. No. ab100790, Abcam, Cambridge, MA) at 4 °C overnight. Subsequently, secondary antibody was added for 30 min, followed by DAB substrate buffer (Abcam, Cambridge, CA) for 5 min. Finally, the sections were counterstained with hematoxylin, dehydrated, and mounted under a coverslip. Immunofluorescence staining was performed according to conventional methods using the following antibodies: α-Amylase For intracellular cytokine staining, splenocytes (1 × 10 6 /well in 96 plates) were stimulated at 37 °C in a CO 2 incubator for 4 hr with Leukocyte Activation Cocktail containing phorbol 12-myristate 13-acetate (PMA), ionomycin, brefeldin A and BD Golgiplug TM . This was followed by staining for cell surface CD4 and intracellular interferon-γ (IFN-γ) (Cat. No. 562020, BD Pharmingen, San Diego, CA) or tumor necrosis factor-α (TNF-α) ( Real-time RT-PCR. Total RNAs were extracted from the pancreatic tissue using PureLink RNA Mini Kit (Invitrogen, Carlsbad, CA). Reverse transcription was performed from 1 μg total RNA using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA), and complementary DNA (cDNA) was used for SYBR green real-time PCR. Amplification was performed with forward and reverse primers using PowerUp TM SYBR Green Master Mix on a QuantStudio TM 7 system (Applied Biosystems, Foster City, CA). The expression of each gene was normalized by corresponding amount of GAPDH mRNA for each condition. Expression of each product were calculated by the comparative ΔΔCt method. Primers are listed in Supplemental Table 2 .
Statistical analysis of expression profiles. The quality of DNA reads, in fastq format, was evaluated using FastQC. Adapters were trimmed, and reads of poor quality or aligning to rRNA sequences were filtered. The cleaned reads were aligned to the Mus musculus genome (mm10) using STAR. Read counts for each gene were calculated using htseq-count in conjunction with a gene annotation file for mm10 obtained from UCSC (University of California Santa Cruz; http://genome.ucsc.edu). Normalization and differential expression were determined using DESeq2 49 . The cutoff for determining significantly differentially expressed genes was an FDR-adjusted p-value less than 0.05. Heat map analysis was performed by Morpheus (https://software.broadinstitute.org/morpheus), and Venn diagrams were drawn with BioVenn.
Pathway enrichment analysis. The enrichment of differentially expressed genes in KEGG pathways were analyzed using GeneCoDis3. Ingenuity Pathway Analysis (IPA) was performed on the differentially expressed genes to identify enriched canonical pathways and gene networks 50 .
